LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LSTA LISATA THERAPEUTICS INC

盘前交易 05-19 08:25:12 EDT

3.12

-0.05

-1.58%

最高3.16	最低3.12	成交量3,691
今开3.16	昨收3.17	日振幅1.10%
总市值2,841万	流通市值2,270万	总股本910.64万
成交额1.16万	换手率0.05%	流通股本727.58万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LSTA","market":"US","secType":"STK","nameCN":"LISATA THERAPEUTICS INC","latestPrice":3.12,"timestamp":1779134400000,"preClose":3.17,"halted":0,"volume":3691,"delay":0,"changeRate":-0.01577287066246051,"floatShares":7275800,"shares":9106391,"eps":-1.86139,"marketStatus":"盘前交易","change":-0.05,"latestTime":"05-19 08:25:12 EDT","open":3.155,"high":3.155,"low":3.12,"amount":11601,"amplitude":0.011041,"askPrice":3.19,"askSize":13,"bidPrice":2.75,"bidSize":179,"shortable":3,"etf":0,"ttmEps":-1.86139,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"adr":0,"listingDate":1186632000000,"exchange":"NASDAQ","adjPreClose":3.12,"postHourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.12,"latestTime":"16:41 EDT","volume":6,"amount":18.7374,"timestamp":1779136893578,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.10703399398229098},"requestUrl":"/m/hq/s/LSTA","defaultTab":"news","newsList":[{"id":"1157369426","title":"Lisata Therapeutics与Kuva Labs达成和解协议 承诺在2026年5月29日前暂停追索权","url":"https://stock-news.laohu8.com/highlight/detail?id=1157369426","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157369426?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:08","pubTimestamp":1777889296,"startTime":"0","endTime":"0","summary":"根据最新提交的美国证券交易委员会文件显示，生物制药企业Lisata Therapeutics Inc已与Kuva Labs达成具有约束力的法律协议。该协议明确规定，在2026年5月29日之前，Lisata将暂缓对Kuva Labs采取任何形式的索赔追索行动。文件未透露双方争议的具体细节，但明确记载了截止日期具有法律效力。资本市场通常对此类阶段性和解持积极看法，因其能有效避免诉讼成本并维持商业关系的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188280634","title":"Lisata Therapeutics与Kuva Labs将股权收购要约截止日期延至2026年4月13日——美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1188280634","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188280634?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:05","pubTimestamp":1775210715,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件，生物制药公司Lisata Therapeutics Inc（以下简称\"Lisata Therapeutics\"）与其合作伙伴Kuva Labs已共同决定，将此前发起的股权收购要约截止日期正式延长至2026年4月13日。\n这一调整意味着潜在投资者现拥有更充裕的时间来评估并参与此次收购行动。延期举措通常反映出交易双方对达成最终协议的持续诚意，同时也为市场留出更充分的响应窗口。\n业内观察人士指出，此类要约期限的延长可能基于多重因素，包括当前市场条件、投资者反馈或交易细节的进一步优化需求。截至公告发布时，双方未披露更多具体条款变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155329362","title":"LISATA THERAPEUTICS INC交易完成后将从纳斯达克退市并终止报告公司身份","url":"https://stock-news.laohu8.com/highlight/detail?id=1155329362","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155329362?lang=zh_cn&edition=full","pubTime":"2026-03-07 07:17","pubTimestamp":1772839030,"startTime":"0","endTime":"0","summary":"LISATA THERAPEUTICS INC宣布，在交易正式完成后，该公司将启动从纳斯达克证券交易所的退市程序，并同时终止其作为证券报告公司的注册义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109236871","title":"Lisata Therapeutics与齐鲁制药就Certepetide许可协议达成共同终止","url":"https://stock-news.laohu8.com/highlight/detail?id=1109236871","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109236871?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518902,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics（股票代码：LSTA）近日宣布，已与齐鲁制药就Certepetide的许可协议达成共同终止协议。双方一致同意终止该协议，结束此前在Certepetide项目上的合作关系。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157804762","title":"行动结果：授予齐鲁的所有许可及其他权利全部回归Lisata Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1157804762","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157804762?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518873,"startTime":"0","endTime":"0","summary":"根据最新行动结果，此前授予齐鲁的所有许可协议及相关权利现已全部归还至Lisata Therapeutics Inc。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198536333","title":"Lisata Therapeutics股价盘前飙升84.26%至3.98美元，获Kuva Labs以每股4美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1198536333","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198536333?lang=zh_cn&edition=full","pubTime":"2026-01-21 21:55","pubTimestamp":1769003712,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics股价在盘前交易中大幅上涨84.26%，报收于3.98美元。此前，该公司宣布将被Kuva Labs以每股4美元的价格全面收购。\n这一收购报价较Lisata Therapeutics近期股价存在显著溢价，反映出市场对该交易的高度认可。受此消息提振，投资者积极买入，推动股价急速攀升。\n生物制药领域再现并购案例，此次交易有望为Lisata Therapeutics的发展注入新动力。市场普遍关注后续收购流程的推进情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178246193","title":"LISATA THERAPEUTICS INC与Kuva Labs签订条款书，将以每股4.00美元的全现金要约收购方式被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1178246193","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178246193?lang=zh_cn&edition=full","pubTime":"2026-01-21 20:01","pubTimestamp":1768996888,"startTime":"0","endTime":"0","summary":"LISATA THERAPEUTICS INC已与Kuva Labs达成一项条款书，根据该协议，Kuva Labs将以每股4.00美元的价格，通过全现金要约收购的方式对LISATA THERAPEUTICS INC进行收购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517466947","title":"Lisata Therapeutics, Inc.2024财年实现净利润-19.99百万美元，同比增加4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517466947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517466947?lang=zh_cn&edition=full","pubTime":"2025-03-08 02:00","pubTimestamp":1741370441,"startTime":"0","endTime":"0","summary":"3月8日，Lisata Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-19.99百万美元，同比增加4.08%；其中营业收入为1000000.00美元，每股基本收益为-2.40美元。从资产负债表来看，Lisata Therapeutics, Inc.总负债5.69百万美元，其中短期债务137000.00美元，资产负债比为6.16，流动比率为6.17。机构评级：截至2025年3月8日，当前有3家机构对Lisata Therapeutics, Inc.目标价做出预测，其中目标均价为17.00美元，其中最低目标价为15.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308020042abed9a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308020042abed9a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517288449","title":"Lisata Therapeutics, Inc.盘中异动 股价大涨8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517288449?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:13","pubTimestamp":1741198384,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时13分，Lisata Therapeutics, Inc.股票出现波动，股价急速拉升8.84%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.38%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021304963b0d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021304963b0d55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514356932","title":"Lisata Therapeutics(LSTA.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.55美元，前值为-0.66美元，预期值为-0.76美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514356932","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514356932?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:00","pubTimestamp":1740693657,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics(LSTA.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.55美元，前值为-0.66美元，预期值为-0.76美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28060048442427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137320550","title":"Lisata Therapeutics 第四季度 GAAP 每股收益 $(0.55) 超出 $(0.79) 的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1137320550","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137320550?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:00","pubTimestamp":1740693652,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics  报告季度每股亏损 $，超出分析师一致预期的 $，超出预期 30.38%。与去年同期每股亏损 $ 相比，这是一种 16.67% 的改善。以上内容来自Benzinga Earnings专栏，原文如下：Lisata $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 30.38 percent. This is a 16.67 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385668","title":"Lisata Therapeutics, Inc.盘中异动 早盘急速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385668?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:44","pubTimestamp":1740667494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时44分，Lisata Therapeutics, Inc.股票出现异动，股价急速拉升5.44%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224454a2567d97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224454a2567d97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514075859","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌7.28%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514075859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514075859?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Lisata Therapeutics, Inc.股票出现波动，股价急速跳水7.28%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4662.94%、160.61%、143.94%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304119893b141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304119893b141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LSTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514323015","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514323015?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:20","pubTimestamp":1740496831,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时20分，Lisata Therapeutics, Inc.股票出现异动，股价急速跳水5.23%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232032989257c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232032989257c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513773368","title":"Lisata Therapeutics, Inc.盘中异动 早盘大幅下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513773368?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:16","pubTimestamp":1740410171,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时16分，Lisata Therapeutics, Inc.股票出现波动，股价快速跳水5.05%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231612962ea39c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231612962ea39c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513213519","title":"Lisata Therapeutics, Inc.盘中异动 急速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213519?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:32","pubTimestamp":1740159140,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时32分，Lisata Therapeutics, Inc.股票出现异动，股价大幅下跌5.15%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013220962ba348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013220962ba348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165183","title":"Lisata Therapeutics, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165183?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:39","pubTimestamp":1739889541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时39分，Lisata Therapeutics, Inc.股票出现异动，股价快速上涨5.78%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223901abd3b0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223901abd3b0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511937619","title":"Lisata Therapeutics, Inc.盘中异动 急速跳水6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511937619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511937619?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:13","pubTimestamp":1739560412,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时13分，Lisata Therapeutics, Inc.股票出现异动，股价快速跳水6.49%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503133296235a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503133296235a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LSTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510331311","title":"Lisata Therapeutics, Inc.盘中异动 早盘急速下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510331311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510331311?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:09","pubTimestamp":1739290160,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时09分，Lisata Therapeutics, Inc.股票出现波动，股价急速下挫5.36%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2770.35%、1222.02%、406.97%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000920abcb1bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212000920abcb1bdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509232923","title":"Lisata Therapeutics, Inc.盘中异动 股价大跌5.70%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509232923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509232923?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:48","pubTimestamp":1738777737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时48分，Lisata Therapeutics, Inc.股票出现异动，股价急速下跌5.70%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.11%。其相关个股中，Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.、Silexion Therapeutics Corp涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4515.51%、2205.73%、1661.41%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206014859abc3a7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206014859abc3a7ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LSTA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lisata.com","stockEarnings":[{"period":"1week","weight":-0.0429},{"period":"1month","weight":-0.0341},{"period":"3month","weight":-0.3158},{"period":"6month","weight":0.5369},{"period":"1year","weight":0.1863},{"period":"ytd","weight":0.6774}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lisata Therapeutics, Inc.根据美国特拉华州法律在Fidelity Medical Services, Inc.的名义下于1980年9月18日注册成立，并于2006年1月在当前市场开始运营。该公司是一家临床阶段的制药公司，致力于发现、开发和商业化治疗实体瘤和其他重大疾病的创新疗法。该公司的主要研究候选产品LSTA1（原名CEND-1）旨在激活一种新的摄取途径，使联合给药或捆绑的抗癌药物能够更有效地穿透实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.263077},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.034282},{"month":3,"riseRate":0.727273,"avgChangeRate":0.051032},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.123948},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.005528},{"month":6,"riseRate":0.6,"avgChangeRate":0.073889},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.054717},{"month":8,"riseRate":0.090909,"avgChangeRate":-0.092076},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.004567},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.121215},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.024316},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.083616}],"exchange":"NASDAQ","name":"LISATA THERAPEUTICS INC","nameEN":"LISATA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供LISATA THERAPEUTICS INC(LSTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"LISATA THERAPEUTICS INC,LSTA,LISATA THERAPEUTICS INC股票,LISATA THERAPEUTICS INC股票老虎,LISATA THERAPEUTICS INC股票老虎国际,LISATA THERAPEUTICS INC行情,LISATA THERAPEUTICS INC股票行情,LISATA THERAPEUTICS INC股价,LISATA THERAPEUTICS INC股市,LISATA THERAPEUTICS INC股票价格,LISATA THERAPEUTICS INC股票交易,LISATA THERAPEUTICS INC股票购买,LISATA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LISATA THERAPEUTICS INC(LSTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供LISATA THERAPEUTICS INC(LSTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}